Press release
Comprehensive 2025 Hepatitis C Market Overview: Trends, Forecasts, and Growth Drivers
Hepatitis C
What Is the Expected CAGR for the Hepatitis C Market Through 2025?
The market size of Hepatitis C has significantly expanded over the last few years. The predicted growth from $67.17 billion in 2024 to $76.32 billion in 2025, equating to a compound annual growth rate (CAGR) of 13.6%, affirms this trend. Factors such as the practice of blood transfusion, usage of injection drugs, scarce treatment alternatives, and the innovation in direct-acting antivirals (DAA's), have powered the growth in this historical phase.
What's the Projected Size of the Global Hepatitis C Market by 2029?
Expectations are set for a swift escalation in the size of the hepatitis C market over the coming years. The market will expand to $134.03 billion by 2029, with a compound annual growth rate (CAGR) of 15.1%. Factors contributing to this anticipated growth during the forecast period include global eradication attempts, enhanced testing and screening, augmentation in healthcare expenditure, integration of telemedicine, and emergence of new therapeutic mixtures. Upcoming trends within this period encompass affordable and readily available treatments, concentrated attention on high-risk demographics, refined drug formulations, collaborative initiatives and partnerships, as well as advancing telehealth and digital solutions.
View the full report here:
https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report
Top Growth Drivers in the Hepatitis C Industry: What's Accelerating the Market?
The growth of the hepatitis C market is projected to accelerate due to an anticipated rise in viral infections. These infections are the result of a virus invading the body. Hepatitis C treatments aid in diminishing viral infections by eliminating the virus and reinstating the patient's immune response following viral clearance. As an example, the Centers for Disease Control and Prevention, a public health agency in the US, reported a surge in Parvovirus B19 cases, a seasonal respiratory viral infection, across all age groups in August 2024. The prevalence escalated from 3% during the period 2022-2024 to 10% in June 2024. This increase was especially noticeable in children aged between 5 and 9 years, where the incidence soared from 15% during 2022-2024 to 40% by June 2024. Furthermore, the number of combined samples showing parvovirus B19 DNA levels showed a remarkable increase from 1.5% in December 2023 to 19.9% in June 2024. Consequently, the surge in viral infections is bolstering the hepatitis C market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12582&type=smp
What Trends Will Shape the Hepatitis C Market Through 2029 and Beyond?
The hepatitis C market is seeing a surge in popularity for the progressive diagnostic technologies for hepatitis C. To maintain their market position, leading businesses in the hepatitis C sector are turning to innovative technologies. To give an example, F. Hoffmann-La Roche Ltd., a pharmaceutical and diagnostics firm based in Switzerland, introduced the Elecsys HCV Duo immunoassay in countries recognizing the CE Mark in July 2022. The immunoassay Elecsys HCV Duo is capable of independently and concurrently determining the hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample. This test can help in detecting patients who are either recuperating or showing signs of a chronic infection that could potentially lead to other illnesses, like liver cancer and initial-stage conditions.
What Are the Main Segments in the Hepatitis C Market?
The hepatitis C market covered in this report is segmented -
1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types
2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments
3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis
4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings
Subsegments:
1) By Chronic Hepatitis C: Genotype 1, Genotype 2, Genotype 3, Genotype 4, Genotype 5, Genotype 6
2) By Acute Hepatitis C: Symptomatic, Asymptomatic
3) By Other Types: Mixed Infections, Superinfection
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12582&type=smp
Which Top Companies are Driving Growth in the Hepatitis C Market?
Major companies operating in the hepatitis C market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., Biocon Limited
Which Regions Will Dominate the Hepatitis C Market Through 2029?
North America was the largest region in the hepatitis C market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis C market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12582
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive 2025 Hepatitis C Market Overview: Trends, Forecasts, and Growth Drivers here
News-ID: 4108230 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Hepatitis
POC Diagnostics Encourages Timely Hepatitis Testing Amid WHO's Hepatitis D Carci …
Birmingham, 18th September, 2025:
The World Health Organization (WHO) recently classified Hepatitis D as a carcinogen and raised a global concern about its link to liver cancer. In response to this, POC Diagnostic, one of the renowned and leading providers of modern medical testing solutions, urges both individuals and healthcare providers to prioritise early Hepatitis recognition.
Timely detection of Hepatitis infections is critical to prevent severe health complications. POC Diagnostics is…
Driving Viral Hepatitis Market Growth in 2025: The Role of Elevated Prevalence O …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Viral Hepatitis Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the viral hepatitis market has experienced consistent growth. It is projected to increase from $16.21 billion in 2024 to $16.93 billion in 2025, representing a compound annual growth rate (CAGR)…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Hepatitis D Market - Defeating Hepatitis D Together: Uniting Against the Silent …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hepatitis D Market.
Hepatitis D Market: https://www.growthplusreports.com/report/hepatitis-d-market/9196
The Hepatitis D Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Hepatitis C Testing Market - Advancing Hepatitis C Elimination Strategies: Embra …
Newark, New Castle, USA: The "Hepatitis C Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hepatitis C Testing Market: https://www.growthplusreports.com/report/hepatitis-c-testing-market/7962
This latest report researches the industry structure,…
